The following clinically significant adverse reactions are described elsewhere in labeling:
• Anaphylaxis, anaphylactic shock, and other serious hypersensitivity reactions [see Warnings and Precautions (5.1)]
• Evacuation of gallstones [see Warnings and Precautions (5.2)]
• Adverse reactions with intravenous injection [see Warnings and Precautions (5.3)]
• Preterm labor or spontaneous abortion [see Warnings and Precautions (5.4)]
The following adverse reactions associated with the use of sincalide were identified in clinical trials or postmarketing reports. Because these reactions were reported voluntarily from a population of uncertain size, it is not always possible to estimate their frequency, reliably, or to establish a causal relationship to drug exposure.
The most frequent adverse reactions (20% or greater) are gastrointestinal: abdominal discomfort or pain, and nausea; these may not necessarily indicate an abnormality of the biliary tract unless there is other clinical or radiologic evidence of disease.
Less common adverse reactions include:
Hypersensitivity reactions: anaphylaxis and anaphylactic shock, hypotension, throat tightness, bradycardia, shortness of breath, nausea, abdominal cramping, diaphoresis, hives, rash, itching; and numbness of face, lips and eyes [see Contraindications (4)].
Neurological reactions: seizures, headache.
Vasovagal reactions: dizziness, loss of consciousness, nausea, diaphoresis, syncope and hypotension (generally self-limiting).
Other: nausea, vomiting, flushing, hypertension, urge to defecate, diarrhea, sneezing.